Mind Medicine (MNMD)
MindMed to Participate in Upcoming Investor Conferences
Viridian Therapeutics Inc. (VRDN)
Viridian Therapeutics Reports Third Quarter 2025 Financial Results and Highlights Recent Progress
BioCryst Pharmaceuticals Inc (BCRX)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Charles River Laboratories International Inc. (CRL)
Charles River Laboratories Provides Update on Strategic Review
MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab
Kodiak Sciences Inc (KOD)
Follow-up data for Kodiaks KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)
EyePoint Pharmaceuticals Inc (EYPT)
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments
Fractyl Health Inc. (GUTS)
Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025
Geron Corp. (GERNW)
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Atea Pharmaceuticals Inc (AVIR)
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025